The availability of high-throughput techniques combined with more exploratory and confirmatory studies in small-molecule science (e.g., probe-and drug-discovery) creates a significant need for structured approaches to data management. The probe-and drug-discovery scientific processes start and end with lower-throughput experiments, connected often by high-throughput cheminformatics, screening, and small-molecule profiling experiments. A rigorous and disciplined approach to data management ensures that data can be used to ask complex questions of assay results, and allows many questions to be answered computationally, without the need for significant manual effort. A structured approach to recording scientific experimental design and observations involves using a consistently maintained set of 'master data' or 'metadata'. Master data include sets of tightly controlled terminology used to describe an experiment, including both materials and methods. Master data can be used at the level of an individual laboratory or with a scope as extensive as a whole community of scientists. Consistent use of master data increases experimental power by allowing data analysis to connect all parts of the discovery life cycle, across experiments performed by different researchers and from different laboratories, thus decreasing the opportunity cost for making novel connections between results. Despite the promise of this increased experimental power, challenges remain in implementation and consistent use of master data management (MDM) techniques in the laboratory. In this paper, we discuss how specific MDM techniques can enhance the quality and utility of scientific data at a project, laboratory, and institutional level. We present a model for storage and exploitation of master data, practical applications of these techniques in the research context of small-molecule science, and specific benefits of MDM to small-molecule screening aimed at probe-and drug-discovery.
INTRODUCTION
In order for both academic and industry researchers to have meaningful access, storage, retrieval, and interpretation of data across the probe-and drug-discovery process, efforts must be made to develop policies and standards for data management. Information must be consistently defined throughout an organization and, if feasible, within a broader experimental domain so that data and their shared context can be understood by both data 'producers' and data 'consumers'. Subsequently, the data used in scientific applications and supporting software tools must have both common syntax and common semantics to enable effective decision-making. This paper describes the design of a central catalog system to manage all master data used across an organization. The benefits of such a catalog within an overall probe-or drug-discovery information technology (IT) architecture are highlighted with an emphasis on the positive impact such a system can deliver to the organization. demonstrate the value of consistent, shared vocabularies to the probe-and drug-discovery processes.
Overview of Theory
Creating and maintaining an accurate working knowledge of the assets of an organization becomes increasingly difficult over time. This is often apparent in a lack of consistency in the use of master data spread across an increasingly diverse set of information systems. Master data are defined as sets of synchronized copies of core business entities used in transactional or analytical applications across the organization, and subjected to enterprise governance policies, along with their associated metadata, attributes, definitions, roles, connections, and taxonomies [1] . Techniques for local master data management (MDM) are now well established within individual systems such as biological data-management systems in support of highthroughput screening or chemical registration systems in support of chemistry and cheminformatics. However, synchronization of terms and dictionaries between such systems remains a challenge and often leads to inconsistencies in the master data. These inconsistencies reduce the value of data and, in the worst case, may lead to repetition of expensive experiments or failure to generate important conclusions from the data.
Maintaining data standards often relies on the manual effort of data managers due to inconsistencies in master data.
In a pharmaceutical setting, these costs can be manifest in a number of ways, including increased manual data curation by expert data managers, extended durations to develop data life-cycle projects (e.g., data warehouses), increased time to track and identify issues in the latter stages of discovery projects, and fragility of integration and interoperability between systems.
In an academic environment, this inconsistency prevents academia from being able to leverage their own data, as well as preventing leverage of public data sources such as PubChem.
Benefits of Master Data Management
Enabling system integration using MDM provides a single source of master data that can be used by a range of software applications within an organization, ensuring both quick and accurate access to the primary information required to conduct experiments. For example, a list of organic compounds an organization has synthesized, and that are available for testing, can be contained within and accessed from a single source, the MDM system. The same master data concept of 'compound' can be used in screening compounds for biological activity, for evaluation of physical sample storage (e.g., to make available for shipment to a contract research organization), and for scale-up or medicinal chemistry development.
A major benefit of MDM is to reduce errors and inconsistencies within a laboratory, a set of experiments, or a whole organization. Master data are the links between systems; recording a result against erroneous master data results in improper or missing linkages between systems. In practical terms, such errors could mean, for example, that a potentially important side effect is missed within the experimental results.
A central data 'catalog' is the essential MDM entity designed to eliminate such problems by maintaining consistency and reducing the cost of future enhancements to the information infrastructure. The catalog should be a fundamental concept within the information-management strategy of any organization, ensuring that information quality is controlled at a single source. The catalog is used to manage not only the system entities themselves, but also the application of those entities. In essence, a catalog is a way to organize and centralize the corporate knowledge contained in the master data.
In the public domain, efforts such as the National Cancer Institute's (NCI) caBIG initiative encourage the use of master data and a central data catalog. Within the caBIG system, system interoperability is defined as the ability of the system to access (syntax) and use (semantics) the parts or equipment of another system [2] [3] [4] [5] . By using an internal central data catalog that integrates publicly available controlled vocabularies and ontologies, scientists are able to make sense of and use more data within the public domain. When this approach is not used within chemical probe and pharmaceutical drug discovery, there is a persistent tension between data 'producers' and data 'consumers'
History of Master Data Management
Early efforts at MDM sparked the "Minimum Information About…" initiatives, resulting in minimum information standards for reporting master data from several experimental platforms. MIAME (Minimum Information About a Microarray Experiment) is perhaps the best-known standardization of data reporting and is used for highthroughput microarray experiments [6] , typically geneexpression arrays. Other MIAxx initiatives have followed; so many, in fact, that an organization, known as MIBBI (Minimum Information for Biological and Biomedical Investigations; http://mibbi.org/) [7] , was formed to collect these standards. A call for standards in small-molecule screening based on MIACA (Minimum Information About a Cellular Assay) was issued in 2007 [8] . However, to date, no global standards for MDM covering the complete life cycle of chemical biology probe-and drug-discovery process have been established.
Master Data Needs in Chemical Biology
Modern chemical biology and drug-discovery efforts seek to identify novel small molecules that potently and selectively modulate the functions of target proteins. Investments in finding new small-molecule probes and drugs typically involve a paradigm of screening large numbers (typically 10 3 -10 6 ) of distinct compounds for those that elicit a desired biological response [9, 10] .
The biological testing component of screening-based discovery has overwhelmingly involved testing compounds for binding to, or inhibition of, purified proteins. In this mode, before conducting a high-throughput screen, the protein target is selected and (typically) purified before exposure to small molecules [11] [12] [13] . The initial selection process, often termed target validation or credentialing, is a time-consuming process that involves demonstrating the relevance of the protein for a particular biological pathway, process, or disease of interest [14] . In some cases, groups of proteins have been purified and tested as panels to understand the selectivity of inhibitors for family members [15, 16] . Once a target or targets has been validated, it is presumed that binders or inhibitors of the target protein will impact the desired process. Often, however, such impact needs to be characterized more completely in cells or animals by observing compound-induced phenotypes. Such follow-up studies provide a first illustration of the need for MDM, as data from the high-throughput screen, cheminformatics, and follow-up functional assays must be integrated for adequate follow-up experimental design.
With advances in assay technology, many research programs are increasingly turning to high-throughput cell-or organism-based phenotypic assays that benefit from preserving the cellular context of protein function [17] . In these assays, the protein target and mechanism of action of the 'interesting' molecules responsible for the observed phenotype remains to be determined. Moreover, even after a relevant target is established, additional functional studies may help to identify unwanted 'off-target' effects or establish new roles for the target protein in biological networks. These important steps in the discovery process, termed target identification or deconvolution [18] , provide a second illustration of the need to integrate data from multiple experiments of different types to optimize and speed analyses across diverse experiments. To do this, a formal MDM scheme for describing both experiments and their cognate components is required (Fig. 1) .
Collection of Controlled Vocabularies, Dictionaries, Ontologies, and Lists
Standardization of master data terms is essential to efficient data analysis, particularly when analyzing data from separate experiments that share experimental features. Collection of metadata using controlled vocabularies (CVs) and established ontologies is an efficient and consistent method of collecting some common master data terms. There are many public ontologies available for use including the Gene Ontology (GO) [19] , Medical Subject Headings (MeSH) (http://www.nlm.nih.gov/mesh/meshhome.html), as well as many others available via the Open Biological and Biomedical Ontologies (OBO) foundry (http://www.obofoundry.org/) [20] . There are several advantages to using publicly available CVs and ontologies. First, they are maintained by external sources and such external maintenance eliminates the need to develop and maintain vocabularies locally. Second, public ontologies are often linked to publicly accessible databases and external resources that can be invaluable for data analysis, and likewise are maintained by others. Third, public ontologies and CVs are generally derived from a consensus of expert scientists in the field. Because most CVs and ontologies are constantly evolving, their use introduces the challenge of keeping them up-to-date if they are stored locally. This challenge can usually be addressed by a regular schedule of updating local CV tables or files, including reporting obsolete terms, and subsequent quality control measures performed on the master data itself.
ChemBank and PubChem are public databases that both use master data management to some extent. ChemBank [21] implements CVs for all master data. These data can be used to mine the biological assays stored in ChemBank, even while many master data fields are not directly searchable via the public interface. ChemBank employs public CVs and ontologies as well as internal CVs relevant to chemical biology experiments and small-molecule screening. This approach allows easy mapping to external data resources and allows flexibility in controlling and expressing master data terms specific to its contents. For example, the internal CVs are used to describe experimental conditions, instrumentation, and detection readout values, while additional, biological information about bioactive small molecules is captured using external ontologies including GO and MeSH.
PubChem [22] captures assay master data at three levels of stringency. First, some master data are captured as free text; the amount of detail contained within this level of master data is at the discretion of the depositor. Second, some master data are specific in meaning but do not adhere to a particular CV. For example, column headers in the Fig. (1) . Chemical biology probe-and drug-discovery process. Across the various types of experiments in the scientific process, master data associated with various sample types can be collected and re-used as master data for experiments themselves in a centralized fashion. Both data-capture and data-retrieval systems can access such centralized master data, enabling analysis across experiments.
PubChem assay results data have names and definitions given by the depositor, but no CV is used for these names. Finally, some PubChem master data are captured in a CV format, such as references to specific small molecules tested (which must already have been registered in PubChem's small molecule deposition system). This most stringent level of master data capture also includes indexed links to other NCBI databases that appear in the PubChem interface. These examples illustrate how different levels of MDM may be appropriate for different information systems. In each case, it is important at the outset to determine likely use-cases for the data, and allow these to drive the desired structure of CVs or ontologies to be used. The data sources and amount of quality control (QC) employed by that source should be considered when determining master data sources for implementation by an organization. In addition, it is important to recognize the need for CVs to grow and evolve, and therefore maintenance of CVs and ontologies should be centralized within an organization to ensure consistency.
Organization and Storage of Master Data
As exemplified above, organizations take a variety of approaches to centralize and manage probe-and drugdiscovery master data. In an environment with a laboratory information management system (LIMS), an electronic laboratory notebook (ELN), or other data-capture solutions, master data may be embedded within the data dictionaries of commercial 'off-the-shelf' applications. Alternatively, larger organizations, particularly multi-national pharmaceutical companies, may have internally developed master data catalogs that control and manage standard vocabularies within a functional or business unit. Given the inherent ambiguities resulting from multiple definitions of a data concept (e.g., 'project' or 'study'), larger organizations have invested effort in multiple data-normalization initiatives, and in the subsequent architectural and integration layers (e.g., web services) to support data integration across functional and business units, such as research and development, manufacturing, and marketing [23] . From a best-practices perspective, the definition of standard data models and data elements in an institutional repository are key elements to the success of both short-and long-term data sharing. The catalog design (vide infra) facilitates data sharing and realizes the goals of MDM both within and between information-management systems.
CATALOG DESIGN STRATEGY
Strategic principles for catalog design have previously been expressed (http://www.edge-ka.com/articles/show/41). Here, we refine and extend these principles and provide a case study of a specific implementation, the BioRails Catalog. A 'catalog' is an organized collection of data lookups or dictionaries that provide a consolidation point for institutional master data. A catalog comprises a number of data 'contexts', which are classification trees for 'concepts'. A concept is used to classify similar dictionaries. Typical concepts in probe-and drug-discovery include 'compounds', 'samples', 'receptors' or 'targets', 'cell lines', and 'species'. Data concepts help to provide a natural data categorization, introducing structure to master data and enabling efficient MDM.
A catalog can be understood as a classic 'conceptual graph', similar to that seen in a number of artificial intelligence systems and more recently in the Semantic Web [24] . We consider the catalog as a simplified version of the ISO/IEC 11179 Metadata Registry (MDR) (http://standards. iso.org/ittf/PubliclyAvailableStandards/), an international standard for representation of metadata from an organization in a metadata registry. Concepts are linked to a number of physical data systems through data elements, which actually implement dictionary look-ups (Fig. 2) . In this way, the catalog introduces a logical separation between concept and realization or implementation, providing a flexible and centralized data representation.
Thus, a catalog provides a single overview for management of all the integrated system dictionaries organized by concepts in a tree. While an individual dictionary may still be managed within another system, all linked applications have access to dictionary entries sourced from the central catalog. The benefits of having a central catalog of dictionaries exceed the convenience of a single source of dictionary look-ups. A catalog provides a consolidation point for institutional memory contained within the master data used across an organization. This structure has the benefit of separating the master data from the mechanics of data capture, thus removing the dependency between data-capture systems and the structure of information owned by the organization. Centralization of MDM enables a consistent and aligned set of terms and concepts to be used across all facets of the organization. Access to a consistent set of dictionaries at the point of data capture improves quality, removing the need to map divergent dictionaries together during data consolidation (e.g., in a data warehouse). MDM thus delivers great benefits to overall data architecture. Liberating the master data from the data-capture systems is an important architectural principle that allows an organization to be more in control of its data contained within the underlying information systems.
Implementing a specific technology solution for MDM relies on three things: 1) source systems that facilitate access to master data; 2) a technical platform for consolidating and categorizing master data; and 3) the existence of transactional systems that can 'consume' the data. The success of this approach is critically dependent on knowledge of MDM approaches and acceptance of those approaches by adopters of business rules and other decisionmakers. A catalog approach is unique among MDM solutions because it supports both a federated and consolidated approach to MDM. Other technical solutions exist that manage master data locally for their own consumption, but very few facilitate usage of master data from wherever data consumers may require access to the data, such as the heterogeneous IT environment of an institutional intranet, or within a cloud storage service on the Internet.
Design Considerations
A number of design considerations should be taken into account before implementing and deploying a catalog: consolidation, conceptual dissonance resolution, centralization, and minimization of transformation.
CONSOLIDATION
Catalog-based MDM techniques rely on maintaining a central consolidated list of master data sourced from multiple master systems. It is important to ensure that any redundant dictionary registration systems are decommissioned before the catalog is deployed into production use. For example, registration of new dictionary entries for a dictionary such as Species should be restricted to a single biological datamanagement application even if there are multiple systems with the same dictionary. This situation may be achieved either using one of the existing data management systems, or be realized within the catalog itself. Isolation of MDM facilitates long-term flexibility in architectural choices and reduces the dependency between data-capture applications and the institutional master data. Existing data-management systems used for transactional data capture must then make use of the master 'Species' concept directly (or by look-up) from the central catalog. All applications source their master data from the same source, often referred to as a 'truth' source, ensuring that in future changes are immediately consistent.
CONCEPTUAL DISSONANCE RESOLUTION
Conceptual dissonance describes the state in which there are conflicts between two uses of a term within different contexts (often different scientific disciplines) within an organization. This situation can relate to different terms that share the same meaning, or to the same term having different meanings depending on the context in which it is used, each a common issue in the highly technical and educated environments of probe-and drug-discovery research. To avoid this phenomenon, a catalog must offer some level of aliasing. For example, the term 'dose' is typically used in high-throughput screening to refer to test concentrations (measured in μM), while during in vivo studies 'dose' almost always refers to a relationship between compound amount and the subject's body weight (measured in mg/kg/day). Another example of two terms with semantically equivalent meanings in a pharmaceutical context is the use of terms 'receptor' and 'target'. Aliasing these terms to one another provides a method of managing these terms without constraining different scientific disciplines to artificial or unfamiliar terms. Aliasing often overcomes one of the key objections to introduction of good MDM practices: negotiation of terminology within large heterogeneous organizations.
CENTRALIZATION
An important technique used to govern master data within an organization is centralization. This strategy provides a guaranteed single system of 'truth' sources that control definition and implementation of master data, in contrast to consolidation of master data which helps to present a single consistent viewpoint from multiple sources. The impact of a poor MDM strategy is most acute for those responsible for data analysis (or data mining). For example, systems used to centralize the definition of 'Assays', including definitions of parameters and their interrelationships, are commonly used by a number of pharmaceutical companies. In order to facilitate the practical aspects of conducting such experiments, these assay definitions are often extended with quality parameters to facilitate data capture. Typically, a document-based approach is used, missing the opportunity to facilitate automatic translation of assay definition into a formal system for capture. Considerable effort may therefore be required to reconcile inputs from multiple data-capture systems. In contrast, if centralized assay definitions are used to define the core data captured during biological research, MDM can reduce the burdens associated with data management, analysis, and interpretation. 
MINIMIZATION OF TRANSFORMATION
A catalog is used to realize an MDM controlling the definition of dictionaries used in transactional data-capture systems. Consistent MDM ensures that the dimensionality of data is enforced at the point of capture, enabling analytical systems to exploit data effectively. In turn, MDM can simplify the data life cycle transitions from transactional systems into long-term storage in a data warehouse. A wellimplemented and maintained catalog reduces the need for complex data transformations and reduces the complexity of data-loading processes. Traditionally, data-warehouse projects are over-complicated because of the lack of MDM, leading to elaborate data-transformation requirements to introduce consistency after data capture. The positive benefit of MDM systems on the implementation of a data warehouse has been recognized by the industry for some time [25, 26] . Industry opinion suggests that data-quality issues should be fixed prospectively, at the source, rather than retrospectively, during data consolidation.
CASE STUDY -BioRails CATALOG
A real-world implementation of an MDM catalog, demonstrating both concepts and feasibility, is BioRails, a biological data-management platform (The Edge Software Consultancy Ltd; Guildford, Surrey, UK). BioRails was designed based on extensive MDM experience in the context of pharmaceutical research and development. BioRails is a zero-client web application implemented in the Ruby on Rails framework, and is available on a range of Linux and Windows platforms. The BioRails catalog can be accessed and used from a range of systems using web services (http://www.edge-ka.com/). A key design element of BioRails is the Catalog, which forms a fundamental component of its Administration module. The Catalog is used to define all dictionaries used within the system. Dictionaries are organized into a number of concepts, and realized as data elements implemented either internally within BioRails or externally within other data systems. The primary role of the Catalog is to serve as a source of dictionary-based parameters for capture of structured data during biological research.
Context, Concepts, and Reference Implementation
The hierarchy of concepts from the root context to the realized dictionary can be visualized as a tree of dictionaries (Fig. 3a) . Parent concepts are displayed as folders within the tree illustrating that they contain child concepts or specializations. For example, the concept Compounds is shown as a child of the parent concept Chemical. The Compounds concept is realized as an implementation on the 'leaf' of the tree. In turn, the Chemical concept is a specialization of the concept Inventory. The concept Inventory contains other categories of inventory concepts such as Biological, Chemical, and Container. Biological inventory concepts are further categorized into concepts such as Animals, Bacteria, Biologic, Neurotoxin, and Targets. The dictionaries tree can be used to explore all the concepts available within the system. Alternatively the concepts can be searched and explored dynamically using web services to search for the appropriate concept for a particular usage.
These dictionaries can be used in a range of environments from transactional systems (e.g., ELN, LIMS) to spreadsheets and other documents.
Data elements represent specific implementations of a higher-level concept. For example, an instance of the BioRails Chemicals concept contains several implementations of that concept (Fig. 3b) . The first implementation, Batches, represents units of manufacture of a compound. This data element is typically realized externally in an inventory system and linked through a structured query language (SQL) statement from an external database. The implementation Compounds is a look-up mapped to an external system using a model that connects a simple identifier with the external compound-registration system, translating a complex external system into a simple identifier look-up. In contrast, the implementations Vehicles and State are realized as internal lists. Hierarchical concepts such as taxonomies can also be created using trees of concepts.
The BioRails Catalog includes an added feature for presenting concepts and their implementations as dictionarybased parameter types. If a parameter type is added to a concept, all look-ups in the concept, including its children, are made available as parameter types for use in defining data-capture protocols. For example, the implementations for Solvent and State (Fig. 3b) are available as parameter types that can be used for recording dictionary-based information. The Catalog can be used to federate and categorize concepts that are implemented in multiple external systems and from various primary data sources (Fig. 3c) , e.g., to support compound registration, reagent inventory, and animal ordering.
Consolidation and Integration
Consolidation and implementation of master data within the BioRails Catalog provides a systematic characterization and structured source of master data. These data can then be used with data from transactional systems capturing data defined against these terms. Most modern information systems support integration via web services. The BioRails Catalog facilitates bidirectional integration: integration of master data defined externally to the Catalog within the Catalog, and access to the consistent master data from any location sourced from the Catalog. This integration simplifies access to master data and provides what has been called a 'single source of truth' [27] .
The BioRails Catalog is designed to provide a modular implementation of the catalog concept. This design means that BioRails can be used to centralize master data independently of the target transactional systems, which is very important for organizations with established transactional systems. For example, commercial datamanagement systems can be adapted to make use of a centralized catalog as a source of master data. The BioRails Catalog model and SQL-based implementations can be used to present a single centralized view of master data from the Catalog even though their precise implementation details are handled and maintained by distinct external systems. MDM systems often make use of service-oriented architectures to deliver master data to transactional systems. The BioRails Catalog provides an extensive set of web services for accessing catalog data.
Other Implementations
In the BioRails example, the catalog-based MDM design is based on public data-management standards (http://stand ards.iso.org/ittf/PubliclyAvailableStandards/). Other commercial and non-commercial implementations of catalog designs are available. Examples include enterprise vocabulary systems, such as those developed by the National Cancer Institute (NCI) (https://cabig.nci.nih.gov/), as well as a number of commercial MDM solutions from suppliers such as SAP (http://www.sdn.sap.com/irj/sdn/mdm/), Initiate (http://www. initiate.com/), Microsoft (http://msdn.microsoft.com/en-us/lib rary/bb190163.aspx), and TIBCO (http://www.tibco.com/so lutions/mdm/default.jsp). Most or all of these solutions target classical customer-product-asset MDM systems. At the time of this writing, we are unaware of adaptations of the catalog design to MDM, other than BioRails, for the complex datamanagement needs of probe-and drug-discovery research.
DISCUSSION
Implementation of an MDM system is challenging in an academic or industrial environment. Scientists are classically trained to record information in individual lab notebooks or their own spreadsheets. This information is neither centralized nor dictated in content or standardization by others. While individual laboratories can certainly benefit from MDM, large, integrative research organizations have a great deal to gain from using well-controlled master data, particularly in using master data for computational studies.
A 'bottom-up' approach can be taken to managing research data by recording master data for experiments in spreadsheets at the time an experiment is done. This master data is specific to each individual experiment and is consistent only within a particular experiment. This approach assures that the master data captured is sufficient to fully describe all experimental metadata that have been deliberately varied. Such an approach, however, results in master data that are not easily mined across experiments and do not have institution-wide CVs.
Conversely, a 'top-down' approach can be taken, developing an internal system for metadata capture either as part of an ELN, as a standardized data-collection procedure involving forms in web-based or local formats, or using a federated catalog approach as described in this article. The top-down approach requires more advance planning and schema design than the bottom-up approach, but nonetheless offers several advantages. First, an organization can determine both the maximum and minimum level of master data it could conceivably capture, then work toward the best solution for the particular application and organization. A top-down MDM approach also has the advantage of readily integrating with outside CVs, ontologies, and other external resources using those CVs. Most important in either of these approaches is sufficient outreach, training, and enforcement of standards to ensure quality and consistency of the master data captured. Implementation of MDM relies on implementation of good governance policies. Technical solutions are only part of the solution and rely on rigorous management.
